Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Merck

Dow Jones Reverses Lower As Powell Warns Of Higher Rates; Trump Returns To Twitter

The Dow Jones reversed lower Friday as Powell warned of higher rates. President Trump returned to X, formerly known as Twitter.

Investors Business Daily

Dow Jones Falls After Surprise Jobless Claims; Nvidia Surges On Earnings

The Dow Jones dropped Thursday after a surprise drop in initial jobless claims. Nvidia surged on strong quarterly earnings results.

Investors Business Daily

Dow Jones Gains As Apple Stock Reboots; Michael Burry Unveils His New Big Short

The Dow Jones was firm as Apple stock rose. Big Short investor Michael Burry placed some new bets. Tesla stock fell on new price cuts.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Top Biotech Roivant, Formed By Vivek Ramaswamy, Reports Steep Losses, Light Sales

Biotech stock Roivant — founded by presidential candidate Vivek Ramaswamy — reported steep losses and lighter sales.

Investors Business Daily

Mirati Rockets 33% On A Bevy Of News In Cancer, A $300 Million Deal And Its CEO Exit

A treatment regimen from Mirati handily beat Merck's blockbuster Keytruda in some lung cancer patients, and MRTX stock rocketed Wednesday.

Investors Business Daily

Merck Stock Today: Why A Bear Call Spread Places $111 In Your Pocket Today

Selling a call spread out of the money in a sideways-to-downside formation has high probabilities of expiring worthless.

Investors Business Daily

3M vs. Merck: Which Dow Dividend Stock is a Better Buy?

MMM and MRK have both underperformed markets in 2023, but offer healthy yields for value-minded investors. Which of these dividend stocks is a better pick for your portfolio right now?

Barchart

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Rises After Key Economic Data; Caterpillar, Merck, Uber Lead 9 Big Earnings Movers

The Dow Jones Industrial Average rose Tuesday after key economic data. Caterpillar, Merck and Uber were among nine big earnings movers.

Investors Business Daily

Merck Posts Narrower-Than Expected Loss, Lifts Sales Outlook on Keytruda Boost

Keytruda cancer-drug sales powered better-than-expected Q2 revenue and a better full-year sales forecast for drugmaker Merck.

The Street

Merck Outplays The Covid Decline, But Prometheus Buyout Weighs On Profits

Merck topped second-quarter expectations Tuesday, though it reported a per-share loss. Merck stock toed the line in response.

Investors Business Daily

Jobs blow as science firm announces redundancies at Scottish plant

A SCOTTISH science and technology company has confirmed that "a small number" of employees are now facing redundancy.

The National (Scotland)

Roche Could Take A Page Out Of Merck's Playbook. Why Roivant Surged.

Roche is in discussions to buy a stomach-disease treatment from Roivant for around $7 billion. The report sent ROIV stock surging Friday.

Investors Business Daily

Dow Jones Rallies 275 Points On Cool Inflation Data; Nike Stock Slides On Earnings Miss

The Dow Jones Industrial Average rallied 275 points Friday on cool inflation data. Nike stock slid after missing Wall Street's earnings estimates.

Investors Business Daily

Dow Jones Rises After Surprise Drop In Jobless Claims, Strong GDP; Cathie Wood Sells $7 Million In Tesla Stock

The Dow Jones rose Thursday after initial jobless claims and Q1 GDP data. Cathie Wood sold more than $7 million in Tesla stock.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Falls As Powell Warns Of More Rate Hikes; AMD, Nvidia Slide On AI Chip Export Ban Report

The Dow Jones fell Wednesday as Powell warned of more rate hikes this year. AMD and Nvidia slid on a reported new ban on AI chips to China.

The Conversation

'The dirty disease' – both smokers and non-smokers get lung cancer. They face stigma on top of illness

Earlier this year, federal health minister Mark Butler announced a new national Lung Cancer Screening Program. The first of its kind for lung cancer, the screening program will open initially to current and former smokers aged 50 to 70 years by July 2025. It aims to save lives by detecting…

Investors Business Daily

Dow Jones Rises After Key Economic Data; Walgreens Plunges On Earnings Miss

The Dow Jones Industrial Average rose Tuesday after key economic data. Walgreens dived after missing Wall Street's estimates.

Investors Business Daily

Dow Jones Futures: Stock Market Pullback Continues, What To Do Now; Nvidia, Tesla Sell Off

Dow Jones futures: the stock market pullback continued Monday, here's what to do now. Nvidia and Tesla stock sold off sharply.

Get all your
news in one place.

100’s of premium titles.
One news app.

TechRadar

LCD TVs are dead in the water and OLED is the future

LCD TV screens have stopped innovating, making it crystal clear OLED is the future.

Los Angeles Times

Michael Hiltzik: Merck says it's being 'coerced' into negotiating its drug prices with Medicare. That's nonsense

No one really expected the pharmaceutical industry to lie down and take it when Congress authorized Medicare to start negotiating prices of the prescription drugs it buys for enrollees.

Daily Record

Irvine healthcare firm plan £250,000 solar power project

North Ayrshire Council will decide on the application from Merck.

Investors Business Daily

One Of The Biggest Names In Medicine Just Entered The Obesity Melee. Here's Why Novo, Lilly Still Have An Edge.

Pharma giant Merck unveiled new data for a potential competitor to weight loss drugs from Novo Nordisk and Eli Lilly.

Salon

Merck sues to block lower Medicare costs

The company claims that the plan to allow Medicare to negotiate drug prices violates the First and Fifth Amendments

Reason

Merck Sues HHS, Claims Drug Price Negotiation Program Violates First and Fifth Amendment

Pharma has a "choice": Negotiate with HHS or pay $10 million "tax" per day.

The Independent UK

Merck sues federal government, calling plan to negotiate Medicare drug prices 'extortion'

Merck is suing the federal government over a plan to negotiate Medicare drug prices, calling the program a sham equivalent to extortion

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.